HRS-9432
- Generic Name
- HRS-9432
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
Phase 2
Recruiting
- Conditions
- Patients With Candidemia and/or Invasive Candidiasis
- Interventions
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06194201
- Locations
- 🇨🇳
The First Affiliated Hospital Of University Of South China, Hengyang, Hunan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath